HomeNews

News

News

Delving Into the Braftovi Plus Erbitux FDA Approval for BRAF+ mCRC

Editor -
Braftovi and Erbitux with chemo earned FDA approval for BRAF V600E colorectal most cancers after excessive response charges within the BREAKWATER trial, per...
News

Testing, ESR1 Mutations and Tolerable Choices

Editor -
Scientific Temporary: Biomarker Testing Technique in Second-Line RemedyMost important Dialogue Matters:Strategic method to biomarker testing when transitioning to second-line remedySignificance of liquid biopsy...
News

First-Line Keytruda Combo Elicits OS Ends in Head and Neck Cancers

Editor -
Keytruda plus Efti led to 17.6-month general survival in sufferers with head and neck squamous cell carcinoma and a PD-L1 rating lower than...
News

A Staunch Advocate For Radiation Oncology Nursing and Compassionate Care

Editor -
From left: MICHELE “MICHI” GRAY, RN, OCN and ALLISON OCHOCKI, B.S.N., RNEverybody is aware of somebody who has been affected by most cancers,...
News

A Personalised Method to Bladder Preservation in Urologic Cancers

Editor -
Urologic most cancers care is shifting in the direction of a much less invasive, personalised approache, in response to Dr. Armine Smith. Smith...
1...344345346...672Page 345 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.